about
Molecular mechanisms in multiple myeloma drug resistanceGenome-wide profiling of histone H3 lysine 27 and lysine 4 trimethylation in multiple myeloma reveals the importance of Polycomb gene targeting and highlights EZH2 as a potential therapeutic target.Mitochondrial DNA plasticity is an essential inducer of tumorigenesis.Increased resistance to proteasome inhibitors in multiple myeloma mediated by cIAP2--implications for a combinatorial treatment.Lenalidomide in multiple myeloma.Multiple Myeloma: The Case of the Disappearing Band.MMSA-1 expression pattern in multiple myeloma and its clinical significance.
P2860
Q26776386-AE7EA0A9-9366-463A-9385-3B303C21A8ADQ36916348-F05DE12B-3810-4199-8EF7-A5A9128C894DQ37164396-EE2884D6-35A5-4770-A4CF-1B14A1A346AEQ38868257-683D9002-C35B-4025-9EF4-6886CA86DFA9Q41114130-F4FB360C-4D94-4C95-9BC7-4BBEDBC76342Q47224752-218BD827-316D-4D56-8188-EA16D2185F03Q52907776-74DB34DF-B00D-41C9-8B2C-B6DB603ED40E
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Biology and treatment of myeloma.
@en
type
label
Biology and treatment of myeloma.
@en
prefLabel
Biology and treatment of myeloma.
@en
P2093
P50
P1476
Biology and treatment of myeloma.
@en
P2093
Annamaria Brioli
Faith E Davies
Gareth J Morgan
Lorenzo Melchor
P304
P356
10.1016/J.CLML.2014.06.011
P407
P478
P577
2014-09-01T00:00:00Z